Medicure Inc. Share Price
Stocks
MPH
CA58469E4085
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Toronto S.E.
08:00:43 02/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.890 CAD | +0.35% |
|
+6.25% | +153.51% |
| 09/09 | Medicure Presents Mend-Pnpo Phase 3 Study Design and Baseline Data At the 16Th European Epilepsy Congress | CI |
| 17/08 | Medicure Inc., Q2 2026 Earnings Call, Aug 17, 2026 |
| Market Cap | 3.01Cr 2.11Cr 1.87Cr 1.75Cr 1.6Cr 203.08Cr 3.05Cr 21Cr 8.2Cr 103.42Cr 7.92Cr 7.75Cr 332.19Cr | P/E 2024 |
-8.8x | P/E 2025 | -1.68x |
|---|---|---|---|---|---|
| Enterprise Value | 2.71Cr 1.9Cr 1.69Cr 1.58Cr 1.44Cr 183.19Cr 2.75Cr 19Cr 7.4Cr 93Cr 7.14Cr 6.99Cr 299.65Cr | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.31x |
| Free-Float |
72.7% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MPH | Delayed | |
OTC Markets
| MCUJF | Delayed | |
|
Deutsche Boerse AG
| NGQ1 | Delayed | |
|
Börse Stuttgart
| NGQ1 | Delayed | |
|
Boerse Muenchen
| NGQ1 | Real-time |
Last Transcript: Medicure Inc.
| 1 day | +0.35% | ||
| 1 week | +6.25% | ||
| Current month | +1.76% | ||
| 1 month | +12.45% | ||
| 3 months | +172.64% | ||
| 6 months | +136.89% | ||
| Current year | +153.51% |
| 1 week | 2.7 |  | 2.89 |
| 1 month | 1.38 | | 2.89 |
| Current year | 0.85 | | 2.89 |
| 1 year | 0.85 | | 2.89 |
| 3 years | 0.63 | | 2.89 |
| 5 years | 0.63 | | 2.89 |
| 10 years | 0 | | 10.67 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CEO | Chief Executive Officer | 79 | 15/09/1997 |
James Kinley
DFI | Director of Finance/CFO | 48 | 15/07/2011 |
Reuben Saba
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Albert Friesen
CHM | Chairman | 79 | 15/09/1997 |
Arnold Naimark
BRD | Director/Board Member | 93 | 28/02/2000 |
Brent Fawkes
BRD | Director/Board Member | 56 | 22/01/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/07/26 | Option | Chief Technology Officer | -20,000 | 0.1916% | ||
| 28/03/25 | Option | Chief Technology Officer | 7,500 | 0.0719% | ||
| 28/03/25 | Option | Director | 7,200 | 0.0690% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.35% | +6.25% | +186.14% | +79.50% | 2.11Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.44TCr | |
| -2.69% | -3.22% | +22.46% | +75.37% | 5.93TCr | |
| +1.43% | -0.39% | +4.54% | +34.84% | 4.71TCr | |
| -0.66% | -4.11% | +26.88% | +33.73% | 4.29TCr | |
| -0.17% | -0.18% | +347.70% | +681.81% | 4.41TCr | |
| -2.21% | -2.58% | +1.84% | +96.94% | 4.08TCr | |
| +3.32% | +3.49% | +10.10% | +51.23% | 3.08TCr | |
| -2.68% | +2.92% | +29.63% | +22.72% | 2.93TCr | |
| +0.05% | -7.84% | -28.93% | +328.03% | 2.37TCr | |
| Average | +0.09% | +0.40% | +64.97% | +149.83% | 3.92TCr | |
| Weighted average by Cap. | +0.30% | -0.32% | +56.79% | +149.39% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.19Cr 1.54Cr 1.37Cr 1.28Cr 1.16Cr 148.01Cr 2.22Cr 15Cr 5.98Cr 75Cr 5.77Cr 5.65Cr 242.12Cr | 2.89Cr 2.02Cr 1.8Cr 1.68Cr 1.53Cr 194.96Cr 2.93Cr 20Cr 7.88Cr 99Cr 7.6Cr 7.44Cr 318.91Cr |
| Net income | -10.39L -7L -6L -6L -6L -7.02Cr -10.53L -73.27L -28.36L -3.58Cr -27.37L -26.78L -11Cr | -70.97L -49.8L -44.24L -41.37L -37.7L -48Cr -71.95L -5Cr -1.94Cr -24Cr -1.87Cr -1.83Cr -78Cr |
| Net Debt | -63.17L -44.33L -39.37L -36.82L -33.55L -43Cr -64.04L -4.45Cr -1.72Cr -22Cr -1.66Cr -1.63Cr -70Cr | -29.44L -20.66L -18.35L -17.16L -15.64L -20Cr -29.84L -2.08Cr -80.36L -10Cr -77.57L -75.88L -33Cr |
Employees
38
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | CA$2.890 | +0.35% | 800 |
| 01/26/01 | CA$2.880 | +1.41% | 475 |
| 30/26/30 | CA$2.840 | 0.00% | 1,500 |
| 29/26/29 | CA$2.840 | +4.41% | 8,200 |
| 28/26/28 | CA$2.720 | +2.64% | 3,100 |
- Stock Market
- Stocks
- MPH Stock
Select your edition
All financial news and data tailored to specific country editions
